2011 Compliance FDA Nursing Homes 
CMS.gov
APRIL 15, 2019
Ensuring Safety and Quality in America’s Nursing Homes. Nursing facilities. This duty is especially important when it comes to the care provided for some of the most vulnerable in our society, Americans residing in nursing homes. CMS’ approach to oversight of nursing homes is constantly evolving.
Drug & Device Law
DECEMBER 29, 2023
Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. The FDA’s five reviews of teratogenic risk all came to the same conclusion.
Expert insights. Personalized for you.
51 
Let's personalize your content